Skip to content

BETA BIONICS, INC.

BBNX

CIK 0001674632

← back to feed
Revenue (TTM)
$95.76M
+53.9% YoY Q1 Apr 2026
Net Income (TTM)
−$81.63M
−33.7% YoY Q1 Apr 2026
EPS Diluted (TTM)
−$2.14
+79.0% YoY Q1 Apr 2026
Gross Margin
55.4%
Q1 Apr 2026
Operating Margin
-83.4%
Q1 Apr 2026
Net Margin
-85.2%
Q1 Apr 2026
Free Cash Flow (TTM)
−$56.22M
Q1 Apr 2026
Cash
$30.21M
Q1 Apr 2026
Total Debt
—
Q1 Apr 2026
Shares Outstanding
44.56M sh
Q1 Apr 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings